Literature DB >> 22671952

CD4⁺ and CD8⁺ regulatory T cells (Tregs) are elevated and display an active phenotype in patients with chronic HCV mono-infection and HIV/HCV co-infection.

H J Hartling1, J C Gaardbo, A Ronit, L S Knudsen, H Ullum, B Vainer, M R Clausen, K Skogstrand, J Gerstoft, S D Nielsen.   

Abstract

The aim of this study was to examine regulatory T cells (Tregs) in peripheral blood and liver tissue in patients with chronic hepatitis C virus (HCV) mono-infection and in patients with HIV/HCV co-infection. In a cross-sectional study were included 51 patients with chronic HCV infection, 24 patients with HIV/HCV co-infection and 24 healthy individuals. CD4⁺ and CD8⁺ Tregs were determined using flow cytometry. Fibrosis was examined by transient elastography. Inflammation, fibrosis and Tregs were determined in liver biopsies from 12 patients. Increased frequency of CD4⁺ and CD8⁺ Tregs was found in HIV/HCV co-infected patients [median: 6.4% (IQR: 5.7-6.9) and 1.0% (0.7-1.2), respectively] compared to HCV mono-infected patients [5.6% (4.2-6.3), P = 0.01 and 0.5% (0.3-0.7), P < 0.001, respectively]. Furthermore, HCV mono-infected patients had increased frequencies of Tregs compared with healthy controls (P < 0.05). However, no associations between the frequency of Tregs and fibrosis were found. Furthermore, characterization of CD4⁺ Tregs using CD45RA demonstrated a higher frequency of activated Tregs in both HCV mono-infected and HIV/HCV co-infected patients compared with healthy controls. Finally, number of intrahepatic Tregs was associated with both peripheral CD8⁺ Tregs and intrahepatic inflammation. In conclusion, HCV mono-infected patients and particularly HIV/HCV co-infected patients have increased the frequency of CD4⁺ and CD8⁺ Tregs compared with healthy controls. Furthermore, CD4⁺ Tregs in infected patients displayed an active phenotype. Tregs were not associated with fibrosis, but a positive correlation between intrahepatic Tregs and inflammation was found. Taken together, these results suggest a role for Tregs in the pathogenesis of chronic HCV infection.
© 2012 The Authors. Scandinavian Journal of Immunology © 2012 Blackwell Publishing Ltd.

Entities:  

Mesh:

Year:  2012        PMID: 22671952     DOI: 10.1111/j.1365-3083.2012.02725.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  18 in total

1.  Association of chronic hepatitis C infection with T-cell phenotypes in HIV-negative and HIV-positive women.

Authors:  Mark H Kuniholm; Xianhong Xie; Kathryn Anastos; Robert C Kaplan; Xiaonan Xue; Andrea Kovacs; Marion G Peters; Eric C Seaberg; Audrey L French; Mary A Young; Michael Augenbraun; Jeffrey A Martinson; Kristin A Bush; Alan L Landay; Howard D Strickler
Journal:  J Acquir Immune Defic Syndr       Date:  2014-11-01       Impact factor: 3.731

2.  Sex Differences, Cocaine Use, and Liver Fibrosis Among African Americans in the Miami Adult Studies on HIV Cohort.

Authors:  Gustavo Zarini; Sabrina Sales Martinez; Adriana Campa; Kenneth Sherman; Javier Tamargo; Jacqueline Hernandez Boyer; Colby Teeman; Angelique Johnson; Abraham Degarege; Pedro Greer; Qingyun Liu; Yongjun Huang; Raul Mandler; David Choi; Marianna K Baum
Journal:  J Womens Health (Larchmt)       Date:  2020-01-31       Impact factor: 2.681

Review 3.  Dynamic balance of pro- and anti-inflammatory signals controls disease and limits pathology.

Authors:  Joseph M Cicchese; Stephanie Evans; Caitlin Hult; Louis R Joslyn; Timothy Wessler; Jess A Millar; Simeone Marino; Nicholas A Cilfone; Joshua T Mattila; Jennifer J Linderman; Denise E Kirschner
Journal:  Immunol Rev       Date:  2018-09       Impact factor: 12.988

4.  Association of colonic regulatory T cells with hepatitis C virus pathogenesis and liver pathology.

Authors:  Helal F Hetta; Mohamed A Mekky; Nasr K Khalil; Wegdan A Mohamed; Mohamed A El-Feky; Shabaan H Ahmed; Enas A Daef; Mahmoud I Nassar; Ahmed Medhat; Kenneth E Sherman; Mohamed Tarek M Shata
Journal:  J Gastroenterol Hepatol       Date:  2015-10       Impact factor: 4.029

Review 5.  Molecular pathways: hepatitis C virus, CXCL10, and the inflammatory road to liver cancer.

Authors:  Jessica Brownell; Stephen J Polyak
Journal:  Clin Cancer Res       Date:  2013-01-15       Impact factor: 12.531

6.  Differentially regulated gene expression associated with hepatitis C virus clearance.

Authors:  Carolyn Z Grimes; Lu-Yu Hwang; Peng Wei; Dimpy P Shah; Kelly A Volcik; Eric L Brown
Journal:  J Gen Virol       Date:  2012-11-14       Impact factor: 3.891

7.  Association between IL28B rs12979860 single nucleotide polymorphism and the frequency of colonic Treg in chronically HCV-infected patients.

Authors:  Minesh Mehta; Helal F Hetta; Enass A Abdel-Hameed; Susan D Rouster; MdMonir Hossain; Mohamed A Mekky; Nasr K Khalil; Wegdan A Mohamed; Mohamed A El-Feky; Shabaan H Ahmed; Enas A Daef; Mohamed A El-Mokhtar; Sayed F Abdelwahab; Ahmed Medhat; Kenneth E Sherman; Mohamed Tarek M Shata
Journal:  Arch Virol       Date:  2016-08-20       Impact factor: 2.574

8.  T Regulatory Cell Subpopulations Associated with Recent Ultraviolet Radiation Exposure in a Skin Cancer Screening Cohort.

Authors:  Rebecca S Hesterberg; Rossybelle P Amorrortu; Yayi Zhao; Shalaka Hampras; Afua A Akuffo; Neil Fenske; Basil Cherpelis; Juliana Balliu; Laxmi Vijayan; Pearlie K Epling-Burnette; Dana E Rollison
Journal:  J Immunol       Date:  2018-11-02       Impact factor: 5.422

9.  Hepatitis C Virus-Induced Myeloid-Derived Suppressor Cells Suppress NK Cell IFN-γ Production by Altering Cellular Metabolism via Arginase-1.

Authors:  Celeste C Goh; Krystal M Roggerson; Hai-Chon Lee; Lucy Golden-Mason; Hugo R Rosen; Young S Hahn
Journal:  J Immunol       Date:  2016-01-29       Impact factor: 5.422

10.  Evaluation of immunological indices in HIV-infected patients with chronic hepatitis C in Kazakhstan.

Authors:  Nazgul Sarsekeyeva; Bakhyt Kosherova
Journal:  Int J Gen Med       Date:  2016-05-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.